Detalhe da pesquisa
1.
Enrichment of human CD4+ V(alpha)24/Vbeta11 invariant NKT cells in intrahepatic malignant tumors.
J Immunol
; 182(8): 5140-51, 2009 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19342695
2.
Thymic selection generates a large T cell pool recognizing a self-peptide in humans.
J Exp Med
; 195(4): 485-94, 2002 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-11854361
3.
Degeneracy of antigen recognition as the molecular basis for the high frequency of naive A2/Melan-a peptide multimer(+) CD8(+) T cells in humans.
J Exp Med
; 196(2): 207-16, 2002 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12119345
4.
Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909.
J Clin Invest
; 115(3): 739-46, 2005 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15696196
5.
The human T cell response to melanoma antigens.
Adv Immunol
; 92: 187-224, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-17145305
6.
Ubiquitylation of a melanosomal protein by HECT-E3 ligases serves as sorting signal for lysosomal degradation.
Mol Biol Cell
; 16(4): 1777-87, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15703212
7.
Efficient induction of tumor antigen-specific CD8+ memory T cells by recombinant lentivectors.
Cancer Res
; 66(2): 1155-60, 2006 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16424053
8.
An immunodominant SSX-2-derived epitope recognized by CD4+ T cells in association with HLA-DR.
J Clin Invest
; 113(8): 1225-33, 2004 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15085202
9.
Multiepitope CD8(+) T cell response to a NY-ESO-1 peptide vaccine results in imprecise tumor targeting.
J Clin Invest
; 110(12): 1813-22, 2002 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-12488431
10.
Structural prediction of peptides bound to MHC class I.
J Mol Biol
; 356(2): 521-46, 2006 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-16368108
11.
Dextramers: new generation of fluorescent MHC class I/peptide multimers for visualization of antigen-specific CD8+ T cells.
J Immunol Methods
; 310(1-2): 136-48, 2006 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-16516226
12.
Lack of BRAF mutations in uveal melanoma.
Cancer Res
; 63(18): 5712-5, 2003 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-14522889
13.
Tumor-reactive, SSX-2-specific CD8+ T cells are selectively expanded during immune responses to antigen-expressing tumors in melanoma patients.
Cancer Res
; 63(17): 5601-6, 2003 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14500401
14.
Toward synthetic combinatorial peptide libraries in positional scanning format (PS-SCL)-based identification of CD8+ Tumor-reactive T-Cell Ligands: a comparative analysis of PS-SCL recognition by a single tumor-reactive CD8+ cytolytic T-lymphocyte clone.
Cancer Res
; 62(7): 2058-63, 2002 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11929825
15.
Circulating Tumor-reactive CD8(+) T cells in melanoma patients contain a CD45RA(+)CCR7(-) effector subset exerting ex vivo tumor-specific cytolytic activity.
Cancer Res
; 62(6): 1743-50, 2002 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-11912149
16.
Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance.
Cancer Res
; 64(8): 2865-73, 2004 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15087405
17.
Activation of human melanoma reactive CD8+ T cells by vaccination with an immunogenic peptide analog derived from Melan-A/melanoma antigen recognized by T cells-1.
Clin Cancer Res
; 9(2): 669-77, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12576434
18.
Can hTERT peptide (540-548) -specific CD8 T cells recognize and kill tumor cells?
Cancer Immun
; 2: 14, 2002 Oct 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-12747759
19.
Functional analysis of HLA-A*0201/Melan-A peptide multimer+ CD8+ T cells isolated from an HLA-A*0201- donor: exploring tumor antigen allorestricted recognition.
Cancer Immun
; 2: 7, 2002 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-12747752
20.
Disease-driven T cell activation predicts immune responses to vaccination against melanoma.
Cancer Immun
; 3: 12, 2003 Sep 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-12962476